2021
In this Seminar, we highlight the main developments in the field of Alzheimer’s disease. The most recent data indicate that, (…)
Consulter
Older adults experiencing subjective cognitive decline (SCD) have a heightened risk of developing dementia and frequently experience subclinical anxiety, which (…)
Consulter
2021
Dual-phase [18F]AV45 positron emission tomography (PET) is highly promising in the assessment of neurodegenerative diseases, allowing to obtain information on (…)
Consulter
2021
Mindfulness-based programs (MBPs) are increasingly utilized to improve mental health. Interest in the putative effects of MBPs on cognitive function (…)
Consulter
2021
Alzheimer’s disease (AD) represents a major health and societal issue; there is no treatment to date and the pathophysiological mechanisms (…)
Consulter
2021
Medial temporal lobe (MTL) atrophy is a key feature of Alzheimer’s disease (AD), however, it also occurs in typical aging. (…)
Consulter